279 related articles for article (PubMed ID: 25170921)
1. Construction and analysis of the protein-protein interaction networks based on gene expression profiles of Parkinson's disease.
Rakshit H; Rathi N; Roy D
PLoS One; 2014; 9(8):e103047. PubMed ID: 25170921
[TBL] [Abstract][Full Text] [Related]
2. Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.
George G; Valiya Parambath S; Lokappa SB; Varkey J
Gene; 2019 May; 697():67-77. PubMed ID: 30776463
[TBL] [Abstract][Full Text] [Related]
3. Integrative analysis of gene expression profiles of substantia nigra identifies potential diagnosis biomarkers in Parkinson's disease.
Huang J; Li B; Wei H; Li C; Liu C; Mi H; Chen S
Sci Rep; 2024 Jan; 14(1):2167. PubMed ID: 38272954
[TBL] [Abstract][Full Text] [Related]
4. An Integrated Network Analysis of mRNA and Gene Expression Profiles in Parkinson's Disease.
Wang Y; Wang Z
Med Sci Monit; 2020 Mar; 26():e920846. PubMed ID: 32210219
[TBL] [Abstract][Full Text] [Related]
5. Construction and analysis of the protein-protein interaction networks for schizophrenia, bipolar disorder, and major depression.
Lee SA; Tsao TT; Yang KC; Lin H; Kuo YL; Hsu CH; Lee WK; Huang KC; Kao CY
BMC Bioinformatics; 2011; 12 Suppl 13(Suppl 13):S20. PubMed ID: 22373040
[TBL] [Abstract][Full Text] [Related]
6. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
[TBL] [Abstract][Full Text] [Related]
7. Correcting Differential Gene Expression Analysis for Cyto-Architectural Alterations in Substantia Nigra of Parkinson's Disease Patients Reveals Known and Potential Novel Disease-Associated Genes and Pathways.
Ferraro F; Fevga C; Bonifati V; Mandemakers W; Mahfouz A; Reinders M
Cells; 2022 Jan; 11(2):. PubMed ID: 35053314
[TBL] [Abstract][Full Text] [Related]
8. Identification of Critical Genes and miRNAs Associated with the Development of Parkinson's Disease.
Li J; Sun Y; Chen J
J Mol Neurosci; 2018 Aug; 65(4):527-535. PubMed ID: 30083784
[TBL] [Abstract][Full Text] [Related]
9. Weighted Gene Coexpression Network Analysis Uncovers Critical Genes and Pathways for Multiple Brain Regions in Parkinson's Disease.
Huang J; Liu L; Qin L; Huang H; Li X
Biomed Res Int; 2021; 2021():6616434. PubMed ID: 33791366
[TBL] [Abstract][Full Text] [Related]
10. Complementary Transcriptomic and Proteomic Analysis in the Substantia Nigra of Parkinson's Disease.
Dong BH; Niu ZQ; Zhang JT; Zhou YJ; Meng FM; Dong AQ
Dis Markers; 2021; 2021():2148820. PubMed ID: 34659588
[TBL] [Abstract][Full Text] [Related]
11. Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death.
Bossers K; Meerhoff G; Balesar R; van Dongen JW; Kruse CG; Swaab DF; Verhaagen J
Brain Pathol; 2009 Jan; 19(1):91-107. PubMed ID: 18462474
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatic analysis for the identification of key candidate genes and pathways in the substantia nigra in Parkinson's disease.
Liu H; Huang Y; Li J
J Integr Neurosci; 2018; 17(3-4):619-631. PubMed ID: 30010140
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's Disease Master Regulators on Substantia Nigra and Frontal Cortex and Their Use for Drug Repositioning.
Vargas DM; De Bastiani MA; Parsons RB; Klamt F
Mol Neurobiol; 2021 Apr; 58(4):1517-1534. PubMed ID: 33211252
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology.
Simunovic F; Yi M; Wang Y; Macey L; Brown LT; Krichevsky AM; Andersen SL; Stephens RM; Benes FM; Sonntag KC
Brain; 2009 Jul; 132(Pt 7):1795-809. PubMed ID: 19052140
[TBL] [Abstract][Full Text] [Related]
15. Multimodal analysis of gene expression from postmortem brains and blood identifies synaptic vesicle trafficking genes to be associated with Parkinson's disease.
Gao X; Huang Z; Feng C; Guan C; Li R; Xie H; Chen J; Li M; Que R; Deng B; Cao P; Li M; Lu J; Huang Y; Li M; Yang W; Yang X; Wen C; Liang X; Yang Q; Chao YX; Chan LL; Yenari MA; Jin K; Chaudhuri KR; Zhang J; Tan EK; Wang Q
Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33079984
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of public microarray data identifies biological regulatory networks in Parkinson's disease.
Su L; Wang C; Zheng C; Wei H; Song X
BMC Med Genomics; 2018 Apr; 11(1):40. PubMed ID: 29653596
[TBL] [Abstract][Full Text] [Related]
17. Mass Spectrometry-Based Proteomics Analysis of Human Substantia Nigra From Parkinson's Disease Patients Identifies Multiple Pathways Potentially Involved in the Disease.
Jang Y; Pletnikova O; Troncoso JC; Pantelyat AY; Dawson TM; Rosenthal LS; Na CH
Mol Cell Proteomics; 2023 Jan; 22(1):100452. PubMed ID: 36423813
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic profiling of differentially expressed genes and related pathways in different brain regions in Parkinson's disease.
Jia E; Pan M; Liu Z; Zhou Y; Zhao X; Dong J; Bai Y; Ge Q
Neurosci Lett; 2020 Jul; 732():135074. PubMed ID: 32446776
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic profiles in Parkinson's disease.
Kurvits L; Lättekivi F; Reimann E; Kadastik-Eerme L; Kasterpalu KM; Kõks S; Taba P; Planken A
Exp Biol Med (Maywood); 2021 Mar; 246(5):584-595. PubMed ID: 33148011
[TBL] [Abstract][Full Text] [Related]
20. Gene Prioritization in Parkinson's Disease Using Human Protein-Protein Interaction Network.
Prajapati R; Emerson IA
J Comput Biol; 2020 Nov; 27(11):1610-1621. PubMed ID: 32343917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
